Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS · Delayed Price · Currency is USD
44.40
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
Otsuka Holdings Market Cap
Otsuka Holdings has a market cap or net worth of $28.17 billion as of August 14, 2025. Its market cap has increased by 11.16% in one year.
Market Cap
28.17B
Enterprise Value
27.25B
Revenue
16.65B
Ranking
n/a
PE Ratio
9.94
Stock Price
$44.40
Market Cap Chart
Since December 15, 2010, Otsuka Holdings's market cap has increased from 12.15B to 28.17B, an increase of 131.91%. That is a compound annual growth rate of 5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 28.17B | -4.16% |
| Dec 30, 2024 | 29.39B | 44.33% |
| Dec 29, 2023 | 20.36B | 14.95% |
| Dec 30, 2022 | 17.71B | -9.80% |
| Dec 30, 2021 | 19.64B | -15.33% |
| Dec 30, 2020 | 23.19B | -4.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.75M |